Sepha's Multi-bottle Leak and Seal Tester - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Sepha's Multi-bottle Leak and Seal Tester



Untitled Document

Sepha, a Belfast, Ireland based company launched BottleScan, a multibottle integrity tester for induction-sealed pharmaceutical bottles. BottleScan uses force-decay technology to detect weak seals and defects down to 15 microns. It has a toolless design and can test up to four bottles simultaneously in a cycle of approximately 60 seconds. The system produces objective, pass-or-fail results enabling good bottles to be returned to the production line. BottleScan has the ability to run in compliance with 21 CFR Part 11, offering pharmaceutical manufacturers and packagers a solution for testing the integrity of induction-sealed bottles.

Source: Sepha

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here